Država: Velika Britanija
Jezik: angleščina
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Magnesium aspartate
magnesium 10mmol) oral powder sachets (Kora Healthcare
A12CC05
Magnesium aspartate
243mg
Powder for oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09050103; GTIN: 5391500440287
OBJECT 1 MAGNASPARTATE 243MG POWDER FOR ORAL SOLUTION Summary of Product Characteristics Updated 13-Jun-2017 | Kora Healthcare 1. Name of the medicinal product Magnaspartate 243 mg powder for oral solution 2. Qualitative and quantitative composition Each 6.5 g sachet of powder contains magnesium aspartate dihydrate equivalent to 243 mg (10 mmol) of magnesium. Excipient(s) with known effect: Each sachet contains 2.706g sucrose For the full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for oral solution White powder with a peach/apricot-like flavour. 4. Clinical particulars 4.1 Therapeutic indications Treatment and prevention of magnesium deficiency, as diagnosed by a doctor. Magnaspartate is indicated in adults, children and adolescents aged from 2 years. 4.2 Posology and method of administration Posology ADULTS (> 18 YEARS) 1-2 sachets daily (243-486 mg magnesium or 10-20 mmol magnesium) CHILDREN AND ADOLESCENTS: 10 TO 18 YEARS 1 sachet daily, (243 mg magnesium or 10 mmol magnesium) CHILDREN: 4-10 YEARS One level 5ml spoon daily (109 mg magnesium) or One sachet daily (243 mg magnesium). CHILDREN: 2 TO 4 YEARS One level 5ml spoon daily. (109 mg magnesium or 4.5mmol magnesium) The safety and efficacy of Magnaspartate in children below 2 years has not been established RENAL PATIENTS: Magnaspartate 243 mg is contraindicated in patients with severe renal impairment (see section 4.3). There is no dose adjustment necessary in patients with mild to moderate renal impairment. ELDERLY: No dose adjustment is necessary. Method of administration For oral use after solution in water, tea or orange juice. Magnaspartate can be dissolved in 50-200mL water, tea or orange juice. Stir until the solution in water is cloudy to transparent. In orange juice or tea inactive particles will be visible. The solution should be taken immediately after being prepared. Discard any remaining content of the sachet. _Note_ If necessary, Magnaspartate in 200ml water can be administered via a gastric, duodenal, and nasal feeding Preberite celoten dokument